Likewise, the majority of tumor-bearing mice succumbed to T cell lymphoma or solid tumors both in R26+/+Cd19+/creTp53-/- and in R26+/AIDCd19+/creTp53-/- mice (65% and 77% combined frequency, respectively). Here, CD19 is linked to T-cell non-Hodgkin lymphoma.